Redefining the Standard of Care: A Consensus Guideline

The Place of Cryopreserved Amniotic Membrane (CAM) in Treatment Protocols for Cornea-involved Ocular Surface Disease for the Optometrist

Published in early 2020, this consensus guideline has been developed in order to reexamine the role of cryopreserved amniotic membrane (CAM) in the management of cornea-involved ocular surface disease and the preparation of the ocular surface for refractive cataract surgery, all of which present continued unmet needs.

Developed from a roundtable discussion with:

Five renowned experts in anterior segment eye disease and surgery highlighted their recommendations for the use of CAM in the following indications:

  • Persistent Epithelial Defect (PED)
  • Corneal Ulcer/Infectious Keratitis
  • Recurrent Corneal Erosion (RCE)
  • Severe Dry Eye Disease (DED)


  • Epithelial Basement Membrane Dystrophy (EBMD)
  • Neurotrophic Keratitis (NK)
  • Optimizing the ocular surface prior to refractive cataract surgery

To download a copy of the Consensus Guideline and view the webinar recording, register for the Physician Portal by clicking the button below: